Study of skin lymphoma factors and possible new targets
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at why skin lymphomas behave differently from person to person and may identify new targets for treatment. You may be invited if you have (or are being evaluated for) a suspected or confirmed skin lymphoma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years old
- Sign an informed consent form (agree to join the study)
- Have a suspicion of skin lymphoma or a confirmed skin lymphoma diagnosis
- Your situation must be under your own legal decision-making (not under guardianship or court-appointed oversight)
- You must be affiliated with social security (have the required coverage/registration)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the bacteria (microbiome) living on the skin in people with specific skin conditions, and in healthy volunteers. The results may help researchers understand what skin microbes have to do with these diseases.
This study aims to understand how common skin lymphomas are in Italy. You might be able to help if you have been diagnosed with a skin lymphoma.
This study looks at what treatments work for people with primary cutaneous lymphoma, and how patients do over time. It uses real patient information from participating hospitals to understand outcomes after diagnosis.
This study collects stored tissue samples (from skin or other needed procedures) from people with CTCL, Sézary syndrome, or lymphomatoid papulosis, especially when you are starting or changing treatment. It’s meant to help researchers learn more about these illnesses and may support future research.
This study collects blood, urine, and possibly small tissue samples to learn more about cutaneous T-cell lymphoma (CTCL) and either eczema or atopic dermatitis. It may help researchers better understand these skin conditions and improve future treatments.
This study reviews medical records of patients treated for cutaneous T-cell lymphoma (a type of blood cancer affecting the skin) at Hospital México in Costa Rica. Researchers will examine how the disease is diagnosed, staged, and treated to better understand patterns and outcomes.
Hear when a new Cutaneous Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.